This is a preprint.
Genomic epidemiology uncovers the timing and origin of the emergence of mpox in humans
- PMID: 38947052
- PMCID: PMC11213064
- DOI: 10.1101/2024.06.18.24309104
Genomic epidemiology uncovers the timing and origin of the emergence of mpox in humans
Abstract
Five years before the 2022-2023 global mpox outbreak Nigeria reported its first cases in nearly 40 years, with the ongoing epidemic since driven by sustained human-to-human transmission. However, limited genomic data has left questions about the timing and origin of the mpox virus' (MPXV) emergence. Here we generated 112 MPXV genomes from Nigeria from 2021-2023. We identify the closest zoonotic outgroup to the human epidemic in southern Nigeria, and estimate that the lineage transmitting from human-to-human emerged around July 2014, circulating cryptically until detected in September 2017. The epidemic originated in Southern Nigeria, particularly Rivers State, which also acted as a persistent and dominant source of viral dissemination to other states. We show that APOBEC3 activity increased MPXV's evolutionary rate twenty-fold during human-to-human transmission. We also show how Delphy, a tool for near-real-time Bayesian phylogenetics, can aid rapid outbreak analytics. Our study sheds light on MPXV's establishment in West Africa before the 2022-2023 global outbreak and highlights the need for improved pathogen surveillance and response.
Conflict of interest statement
Competing interest declaration MAS receives grants and contracts from the U.S. Food & Drug Administration, the U.S. Department of Veterans Affairs and Johnson & Johnson all outside the scope of this work.
Figures











References
-
- McCollum A. M. & Damon I. K. Human monkeypox. Clin. Infect. Dis. 58, 260–267 (2014). - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases